G&E (4911.TWO) monthly revenue, September 2026
G&E reported revenue of NT$0.01bn for September 2026, down 1.1% from the previous month and down 56.0% from a year earlier. Year-to-date revenue was NT$0.10bn, down 57.9% year on year. It ranked 146 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 0.01 | -1.1 | -56.0 |